Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus

Scandinavian Journal of Rheumatology

Volumn 42, Issue 4, 2013, Pages 303-310

  Lozovoy, M A B ^a   Simao A N C ^b   Oliveira, S R ^b   Iryioda, T M V ^b   Panis, C ^b   Cecchini, R ^b   Dichi, I ^b  

^a UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; CARBONYL DERIVATIVE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; PROTEIN; THIOL GROUP; TOTAL RADICA ANTIOXIDANT PARAMETER; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SYSTEMIC LUPUS ERYTHEMATOSUS; URIC ACID BLOOD LEVEL;

ADULT; AGE FACTORS; ANTHROPOMETRY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DINOPROST; DISEASE PROGRESSION; FEMALE; FERRITINS; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84880219071     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.754942     Document Type: Article

References (41)

1. Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity 2010;43:56-63.
2. Sheikh Z, Ahmad R, Sheikh N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 2007;40:512-20. (Pubitemid 351233172)
3. Simao ANC, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008;24:675-81.
4. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 2000;24:23-7.
5. Capper ER,Maskill JK, Gordon C, Blakemore AL. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: Could longitudinal studies reveal patient subgroups of differing pathology? Clin Exp Immunol 2004; 138:348-56. (Pubitemid 39472455)
6. El Magadmi M, Ahmad Y, Turkie W, Yates AP, Sheikh N, Bernstein RM, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in woman with systemic lupus erythematosus. J Rheumatol 2006;33:50-6. (Pubitemid 43054279)
7. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Eng J Med 2003;349:2407-15. (Pubitemid 37542989)
8. Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P, et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: Association with disease characteristic and cardiovascular risk factors. Ann Rheum Dis 2007;66:208-14. (Pubitemid 46226056)
9. Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev 2007;6:457-63. (Pubitemid 47079115)
10. Gonzalez AS, Guerrero DB, Soto MB, Diaz SP, Martinez-Olmos M, Vidal O. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 2006;60:802-9. (Pubitemid 43842236)
11. Choi KM, Lee KW, Seo JA, Kim SG, Kim NH, Choi DS, et al. Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women. Metab Clin Exp 2005;54:1510-14. (Pubitemid 41527022)
12. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000;355:2181-2. (Pubitemid 30394321)
13. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95. (Pubitemid 30010408)
14. Kim C-H, Kim H-K, Bae SJ, Park J-Y, Lee K-U. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metab Clin Exp 2011;60:414-20.
15. Arosio P, Ingrassia R, Cavadini, P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 2009;1790:589-99.
16. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Rad Biol Med 2002;33:457-63. (Pubitemid 34874967)
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
19. Lozovoy MAB, Simao ANC, Panis C, Rotter MAC, Reiche EMV, Morimoto HK, et al. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus 2011;20:1250-9.
20. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087-92. (Pubitemid 27274268)
21. Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Avalos I, et al. Inflammation-associated insulin resistance. Arthritis Rheum 2008;58:2105-12.
22. Flecha BG, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle. Free Rad Biol Med 1991;10:93-100. (Pubitemid 121003216)
23. Witko-Sarsat V, Friedlander M, Khoa TN, Capeillere-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161: 2524-32. (Pubitemid 28397070)
24. Panis C,HerreraAC,VictorinoVJ, Campos FC, Freitas LF, De Rossi T, et al. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 2012;133:89-97.
25. Repetto M, Reides C, Carretero MLG, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta 1996;255:107-17. (Pubitemid 26374053)
26. Hu ML. Measurement of protein thiol groups and glutathione in plasma. In: Abelson JN, Simon MI, editors. Methods in enzymology. San Diego, CA: Academic Press, 1994:380-2.
27. VenturiniD, SimãoANC,ScripesNA,BahlsLD,MeloPAS,Belinetti FM, et al. Evaluation of oxidative stress in overweight subjectswith or without metabolic syndrome. Obesity 2012;20:2361-6.
28. Lee DH, Blomhoff R, Jacobs Jr. DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Rad Res 2004;38:535-9. (Pubitemid 38697087)
29. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk. The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-33. (Pubitemid 46360389)
30. Dichi I, Simao ANC. Metabolic syndrome: New targets for an old problem. Expert Opin Ther Targets 2012;16:1-4.
31. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
32. Zhao G, Bou-Abdallah F, Yang X, Arosio, P, Chasteen ND. Is hydrogen peroxide produced during iron(II) oxidation in mammalian apoferritins? Biochemistry 2001;40:10832-8. (Pubitemid 32835025)
33. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochim Biophys Acta 2010; 1800:760-9.
34. Beyan E, Beyan C, Demirezer A, Ertugrul E, Uzuner A. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 2003;32:225-8. (Pubitemid 37266962)
35. Lim MK, Lee CK, Ju YS, Cho YS, Lee MS, Yoo B, et al. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus. Rheumatol Int 2001;20:89-93. (Pubitemid 32250118)
36. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002;99:3505-16. (Pubitemid 34534516)
37. Panis C, Victorino VJ, Herrera ACSA, Freitas LF, De Rossi T, Campos FC, et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat 2012;133:881-8.
38. Grune T, Merker K, Sanding G, Davis KJ. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 2003;305:709-18. (Pubitemid 36579287)
39. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. Sglutathionylation: From redox regulation of protein functions to human diseases. J Cell Mol Med 2004;8:201-12. (Pubitemid 44145509)
40. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling.AmJ Physiol Lung Cell Mol Physiol 2000;279:L1005-28. (Pubitemid 32009487)
41. Chung CP, Titova D, Oeser A, Randels M, Avalos I, Milne GL. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2009;28:435-8.